Treatment Registry
TR-0654 ActiveRecorded September 2026

Oral semaglutide

Sold by Peptivo · every oral semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$249

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Semaglutide Oral+, starting price · recorded initial monthly payment$249

Added from the figures recorded below.

Price

TermPer monthCharged today
Semaglutide Oral+, starting price

“Semaglutide Oral+ High Dose Compounded Oral Medication for Advanced Therapy from $249”

Per month$249Charged today$249
Price sources
Visit Peptivo

We earn nothing from this link. It opens Peptivo's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

StatesAll 50 states
PrescriberAsynchronous review
CancellationIf a subscription is canceled after a charge has been processed: Cancellation will prevent future charges, but previously processed charges are non-refundable.

Not yet checked: pharmacy, membership and consult fee.

Recorded from peptivo.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — 'No Hidden Fees. No Membership Cost' is stated repeatedly, and the per-day medication prices appear to be all-inclusive, so no separate membership entry was recorded. The 'Tirzepatide Oral' SKU has no matching enum ('oral tirzepatide' doesn't exist on this register); recorded as compounded tirzepatide since the page tags it COMPOUNDED. Semaglutide Oral+ and both injections don't state vial vs. pen or tablet vs. sublingual, so form is not-disclosed throughout.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0654
Medication category
oral semaglutide
Readings
1

Related records

Other records from Peptivo

All Peptivo programs and terms

Oral semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 58 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Peptivo — oral semaglutide (TR-0654). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0654

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.